Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness <i>in vivo</i>

Laura E. Wright

Department of Medicine, Division of Endocrinology, Indiana University, Indianapolis, IN, USA
Ahmed A. Harhash

Department of Medicine, Division of Endocrinology, Indiana University, Indianapolis, IN, USA
Wende M. Kozlow

Department of Internal Medicine, Division of Endocrinology, University of Virginia, Charlottesville, VA, USA
David L. Waning

Department of Cellular and Molecular Physiology, The Pennsylvania State University College of Medicine, Hershey, PA, USA
Jenna N. Regan

Department of Medicine, Division of Endocrinology, Indiana University, Indianapolis, IN, USA
Yun She

Department of Medicine, Division of Endocrinology, Indiana University, Indianapolis, IN, USA
Sutha K. John

Department of Medicine, Division of Endocrinology, Indiana University, Indianapolis, IN, USA
Sreemala Murthy

Department of Medicine, Division of Endocrinology, Indiana University, Indianapolis, IN, USA
Maryla Niewolna

Department of Medicine, Division of Endocrinology, Indiana University, Indianapolis, IN, USA
Andrew R. Marks

Department of Physiology, Columbia University, New York, NY, USA
Khalid S. Mohammad

Department of Medicine, Division of Endocrinology, Indiana University, Indianapolis, IN, USA
Theresa A. Guise

Department of Medicine, Division of Endocrinology, Indiana University, Indianapolis, IN, USA

収録刊行物